
FXR
Farnesoid X Receptor (FXR) is a nuclear receptor that plays a key role in the regulation of bile acid homeostasis, lipid metabolism, and glucose regulation. FXR is a potential therapeutic target for treating liver diseases, metabolic disorders, and cardiovascular diseases. FXR inhibitors can modulate these pathways, offering insights into disease mechanisms and therapeutic strategies. At CymitQuimica, we provide a range of FXR inhibitors to support your research in hepatology, metabolism, and drug development.
Found 58 products of "FXR"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
ST-1892
CAS:<p>ST-1892 is a soluble partial FXR agonist.</p>Formula:C16H12N2O3Purity:98%Color and Shape:SolidMolecular weight:280.28PX20606
CAS:<p>PX20606 is an orally active farnesoid X receptor (FXR) agonist, demonstrating EC50 values of 220 nM (mFXR) and 50 nM (hFXR) in Gal4-FXR assays. It induces the expression of the tumor suppressor gene NDRG2 and inhibits tumor growth and metastasis in a mouse HCC model. Additionally, PX20606 exhibits hepatoprotective properties.</p>Formula:C29H22Cl3NO4Color and Shape:SolidMolecular weight:554.85FXR agonist 4
<p>FXR agonist 4: EC50 of 1.05μM, treats hyperlipidemia, steatosis, insulin resistance, inflammation in DIO mice, for NAFLD research.</p>Formula:C21H28ClN3OColor and Shape:SolidMolecular weight:373.92LY367385
CAS:<p>LY367385 is a highly effective and selective mGluR1a antagonist.</p>Formula:C10H11NO4Purity:98%Color and Shape:SolidMolecular weight:209.2Fexarine
CAS:<p>Fexarine is a potent, selective agonist of farnesoid X receptor.</p>Formula:C31H31NO5Color and Shape:SolidMolecular weight:497.58GSK-8062
CAS:<p>GSK-8062 is an agonist of farnesoid X receptor (FXR).</p>Formula:C30H23Cl2NO4Purity:98%Color and Shape:SolidMolecular weight:532.41BMS-986318
CAS:<p>BMS-986318: potent FXR agonist, EC50=53/350 nM, good ADME, effective in liver disease models, for nonalcoholic steatohepatitis research.</p>Formula:C30H23Cl2F3N4O3Color and Shape:SolidMolecular weight:615.43FXR antagonist 1
CAS:<p>"Oral FXR antagonist 1 selectively blocks intestinal FXR, with IC50 of 2.1 μM, aiding in NASH research by improving liver health."</p>Formula:C36H59NO5Color and Shape:SolidMolecular weight:585.86GSK2324
CAS:<p>GSK2324 is a potent FXR agonist for the treatment of NAFLD by controlling hepatic lipids through reduced uptake and selective reduction of fatty acid synthesis.</p>Formula:C29H22Cl2N2O4Purity:98.09% - 99.02%Color and Shape:SolidMolecular weight:533.4FXR agonist 9
CAS:<p>FXR agonist9 (compound 26) is a selective, orally active partial agonist of FXR with an EC50 of 0.09 µM (maximum efficacy of 75.13%). It ameliorates the pathological features of fatty liver disease in mice induced by HFD and CCl4-related metabolic dysfunction.</p>Formula:C28H30N2O5Color and Shape:SolidMolecular weight:474.55Omesdafexor
CAS:<p>Omesdafexor is an FXR agonist that can be used to study diseases caused by liver disease or metabolic inflammation.</p>Formula:C34H43N3O3Color and Shape:SolidMolecular weight:541.72NR1H4 activator 1
CAS:<p>NR1H4 activator 1 is a potent and selective agonist of Famesoid X Receptor (FXR).</p>Formula:C34H53NO7SPurity:98%Color and Shape:SolidMolecular weight:619.85FXR agonist 12
CAS:<p>FXR agonist12 (Compound C7) is an orally active FXR agonist. It downregulates bile acid synthesis-related genes and upregulates bile acid transport-related genes in HepG2 cells. FXR agonist12 alleviates ANIT-induced cholestasis and reduces liver damage and fibrosis in a mouse model of NASH.</p>Formula:C26H44O3Color and Shape:SolidMolecular weight:404.626BMS-986339
CAS:<p>BMS-986339: oral, potent FXR agonist; binds to His298/ASN287; for PBC, PSC, NASH, anti-fibrosis research.</p>Formula:C35H41F4N3O4Color and Shape:SolidMolecular weight:643.71Danifexor
CAS:<p>Danifexor is an agonist of the farnesoid X receptor (Farnesoid X receptor).</p>Formula:C29H20Cl2N2O5Color and Shape:SolidMolecular weight:547.386FXR/CES2 modulator 1
CAS:<p>Compound LE-77, known as FXR/CES2 modulator 1, functions as a dual regulator that activates FXR and inhibits CES2. It effectively mitigates the intestinal toxicity of irinotecan.</p>Formula:C27H21Cl2NO5Color and Shape:SolidMolecular weight:510.36Lecufexor
CAS:<p>Lecufexor is an agonist of the farnesoid X receptor (FXR).</p>Formula:C32H21Cl3N2O5Color and Shape:SolidMolecular weight:619.88BAR-2227
CAS:<p>BAR-2227 (compound 3a) functions as an FXR agonist and a LIFR inhibitor. It is utilized in the study of liver fibrosis and inflammation.</p>Formula:C24H17Cl2NO4Color and Shape:SolidMolecular weight:454.30
